Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 06:41PM
|
Re: ZHCLF
|
6
|
Zenith Epigenetics
|
Feb 01, 2024 10:55AM
|
Re: Expectations for the AGM?
|
6
|
Resverlogix Corp.
|
Dec 06, 2020 02:47PM
|
Re: No news
|
6
|
Resverlogix Corp.
|
Sep 17, 2022 08:12AM
|
Re: I just can’t see the management going
|
6
|
Resverlogix Corp.
|
Oct 29, 2019 09:20AM
|
Re: Still waiting for a sufficient answer
|
6
|
Resverlogix Corp.
|
May 22, 2018 04:36PM
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
6
|
Zenith Epigenetics
|
Sep 26, 2024 01:29PM
|
Re: SP 884+ Week Low.
|
6
|
Resverlogix Corp.
|
Oct 16, 2022 09:01AM
|
Re: Epigenetics and Coronavirus
|
6
|
Resverlogix Corp.
|
Mar 23, 2020 10:42AM
|
Re: Should I do a blog posting about Resverlogix?
|
6
|
Resverlogix Corp.
|
Apr 30, 2016 12:48PM
|
Re: Where's the kool aid gang?
|
6
|
Resverlogix Corp.
|
May 20, 2022 06:44PM
|
Amarin Patent issue and Litigation
|
6
|
Resverlogix Corp.
|
Mar 31, 2020 10:03AM
|
Re: Option #2
|
6
|
Resverlogix Corp.
|
Sep 11, 2020 07:04AM
|
Re: So how long have they been sitting on the FDA response?
|
6
|
Resverlogix Corp.
|
Sep 07, 2022 06:45PM
|
Re: What's the deal with Zenith?
|
6
|
Zenith Epigenetics
|
Jun 24, 2023 02:29PM
|
Re: Nasdaq listing -- Awesome News!!
|
6
|
Resverlogix Corp.
|
Jul 31, 2018 05:49PM
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
6
|
Resverlogix Corp.
|
Nov 10, 2021 12:53PM
|
Re: Qatar Research overview of apabetalone
|
6
|
Resverlogix Corp.
|
Apr 24, 2024 12:36PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 26, 2022 09:10AM
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
6
|
Resverlogix Corp.
|
Jun 22, 2022 12:55PM
|